Hansa Biopharma AB (OSTO:HNSA) Days Payable : 437.03 (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hansa Biopharma AB Days Payable?

Hansa Biopharma AB's average Accounts Payable for the three months ended in Mar. 2024 was kr87.0 Mil. Hansa Biopharma AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr18.2 Mil. Hence, Hansa Biopharma AB's Days Payable for the three months ended in Mar. 2024 was 437.03.

The historical rank and industry rank for Hansa Biopharma AB's Days Payable or its related term are showing as below:

OSTO:HNSA' s Days Payable Range Over the Past 10 Years
Min: 380.62 Med: 6292.47 Max: 19177.04
Current: 380.62

During the past 13 years, Hansa Biopharma AB's highest Days Payable was 19177.04. The lowest was 380.62. And the median was 6292.47.

OSTO:HNSA's Days Payable is ranked better than
71.09% of 723 companies
in the Biotechnology industry
Industry Median: 149.7 vs OSTO:HNSA: 380.62

Hansa Biopharma AB's Days Payable declined from Mar. 2023 (591.02) to Mar. 2024 (437.03). It may suggest that Hansa Biopharma AB accelerated paying its suppliers.

Hansa Biopharma AB Days Payable Historical Data

The historical data trend for Hansa Biopharma AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansa Biopharma AB Days Payable Chart

Hansa Biopharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

19,177.04

14,139.08

946.86

549.42

431.93

Hansa Biopharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															591.02	-	-	437.80	437.03

Competitive Comparison of Hansa Biopharma AB's Days Payable

For the Biotechnology subindustry, Hansa Biopharma AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hansa Biopharma AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hansa Biopharma AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Hansa Biopharma AB's Days Payable falls into.

Hansa Biopharma AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hansa Biopharma AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (62.476	+	86.966)	/	2 )	/	63.143	*	365
=	74.721					/	63.143	*	365
=	431.93

Hansa Biopharma AB's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (86.966	+	0)	/	1 )	/	18.158	*	365 / 4
=	86.966					/	18.158	*	365 / 4
=	437.03

Hansa Biopharma AB Days Payable Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansa Biopharma AB (OSTO:HNSA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (OSTO:HNSA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

HNSBF:USA 0RC7:UK 24H:Germany

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.hansabiopharma.com

Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB (OSTO:HNSA) Headlines

No Headlines